Details for New Drug Application (NDA): 207523
✉ Email this page to a colleague
The generic ingredient in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.
Summary for 207523
Tradename: | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE |
Applicant: | Somerset |
Ingredient: | dorzolamide hydrochloride; timolol maleate |
Patents: | 0 |
Pharmacology for NDA: 207523
Mechanism of Action | Adrenergic beta-Antagonists Carbonic Anhydrase Inhibitors |
Suppliers and Packaging for NDA: 207523
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 207523 | ANDA | Somerset Therapeutics, LLC | 70069-051 | 70069-051-12 | 12 CARTON in 1 BOX (70069-051-12) / 1 BOTTLE in 1 CARTON (70069-051-01) / 10 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 2% BASE;EQ 0.5% BASE | ||||
Approval Date: | Jun 25, 2019 | TE: | AT1 | RLD: | No |
Complete Access Available with Subscription